Literature DB >> 2275233

Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens.

P L Doering1, T M Santiago.   

Abstract

Various agents are available for the treatment of vulvovaginal candidiasis. Imidazole agents (clotrimazole, miconazole, butoconazole, and terconazole) are preferred because of their greater efficacy, shorter treatment regimens, and ease of administration. Although the various imidazole compounds are equally efficacious, different treatment schedules are recommended depending on clinical situations. Additionally, different formulations are available that provide clinicians and patients with the opportunity to select the most appropriate agent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2275233     DOI: 10.1177/106002809002401112

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


  3 in total

Review 1.  Vaginal yeast infections during pregnancy.

Authors:  Derrick Soong; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2009-03       Impact factor: 3.275

Review 2.  Clinical and cost considerations in the pharmacotherapy of vulvovaginal candidiasis.

Authors:  I W Fong
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

3.  The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.

Authors:  J H Gurwitz; T J McLaughlin; L S Fish
Journal:  Health Serv Res       Date:  1995-12       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.